Share Your Research

Important Information

1. No figures or tables may be included in abstract submissions.
2. Only abstracts submitted online through the HemeNext Abstract submission portal will be considered.
3. You retain the copyright of your content and agree to give RSNA a limited, nonexclusive, royalty-free license to present and archive the content.
4. All abstracts are evaluated through a double-blind peer-review process.
5. More than 1 author is not permitted.
6. 4500 character limit: The title, authors’ names, and authors’ affiliations are not included in the character count.
7. Abstract should be structured (Background/Obj, Methods, Results, Conclusion).
8. Use standard abbreviations. Place abbreviations in parentheses immediately after the first mention.
9. Names of all co-authors and their institutional affiliations must be provided.
10. Changes will not be made to the spelling of authors’ names, or the order of co-authors, after the submission deadline.

Abstract Content Guidelines

• An abstract must include primary new scientific, clinical, meta-analytic, health outcomes, or epidemiologic data. The only exceptions are Trials in Progress abstracts.
• ASH expects all scientific research submitted to conform to generally accepted standards of scientific integrity regarding experimental design, data collection, analysis, and interpretation.
• All studies involving human and animal subjects must comply with the guiding principles found in the Declaration of Helsinki.
• Data from long-term follow-up or additional accrual may be submitted only if it includes significant new information (use the Updated Analyses section).
• Interim analysis of a prospective randomized clinical trial will be considered only if planned in the original protocol or closed early due to toxicity, futility, or benefit.